The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults

Influenza and other Respiratory Viruses

Volumn 5, Issue 2, 2011, Pages 67-75

  Ambrose, Christopher S ^a   Levin, Myron J ^b   Belshe, Robert B ^c  

^a MEDIMMUNE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adults; Inactivated influenza vaccine; Influenza; Live attenuated influenza vaccine; Pediatrics

Indexed keywords

INFLUENZA VACCINE; LIVE VACCINE; PLACEBO; TRIPLE VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; COUGHING; DECREASED APPETITE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEVER; FLU LIKE SYNDROME; HEADACHE; HUMAN; INCIDENCE; INFANT; INFLUENZA; INFLUENZA VACCINATION; INJECTION SITE REACTION; MYALGIA; NOSE CONGESTION; PRIORITY JOURNAL; REVIEW; RHINORRHEA; SORE THROAT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VACCINATION; VACCINES, ATTENUATED; VACCINES, INACTIVATED;

EID: 79751480796     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/j.1750-2659.2010.00183.x     Document Type: Review

References (32)

1. Fiore AE, Shay DK, Broder K et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009; 58:1-52.
2. Ashkenazi S, Vertruyen A, Aristegui J et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr Infect Dis J 2006; 25:870-879.
3. Fleming DM, Crovari P, Wahn U et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J 2006; 25:860-869.
4. Belshe RB, Toback SL, Yi T, Ambrose CS. Efficacy of live attenuated influenza vaccine in children 6months to 17years of age. Influenza Other Respir Viruses 2010; 4:141-145.
5. Belshe RB, Edwards KM, Vesikari T et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007; 356:685-696.
6. Yang CF, Belshe RB, Kemble G et al. Genetic sequence analysis of influenza viruses and illness severity in ill children previously vaccinated with live attenuated or inactivated influenza vaccine. Vaccine 2010; 28:5128-5134.
7. Piedra PA, Gaglani MJ, Kozinetz CA et al. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Pediatrics 2007; 120:e553-e564.
8. Halloran ME, Piedra PA, Longini IM Jr et al. Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004. Vaccine 2007; 25:4038-4045.
9. Treanor JJ, Kotloff K, Betts RF et al. Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses. Vaccine 1999; 18:899-906.
10. Monto AS, Ohmit SE, Petrie JG et al. Comparative efficacy of inactivated and live attenuated influenza vaccines. N Engl J Med 2009; 361:1260-1267.
11. Ohmit SE, Victor JC, Rotthoff JR et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med 2006; 355:2513-2522.
12. Ohmit SE, Victor JC, Teich ER et al. Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines. J Infect Dis 2008; 198:312-317.
13. Wang Z, Tobler S, Roayaei J, Eick A. Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel. JAMA 2009; 301:945-953.
14. Eick AA, Wang Z, Hughes H, Ford SM, Tobler SK. Comparison of the trivalent live attenuated vs. inactivated influenza vaccines among U.S. military service members. Vaccine 2009; 27:3568-3575.
15. Bridges CB, Thompson WW, Meltzer MI et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 2000; 284:1655-1663.
16. Nichol KL, Mendelman PM, Mallon KP et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA 1999; 282:137-144.
17. Forrest BD, Steele AD, Hiemstra LA, Rappaport R, Ambrose CS, Gruber WC. A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60years of age and older. Options for the Control of Influenza VII; 2010 September 3-7; Hong Kong SAR, China.
18. De Villiers PJ, Steele AD, Hiemstra LA et al. Efficacy and safety of a live attenuated influenza vaccine in adults 60years of age and older. Vaccine 2009; 28:228-234.
19. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994; 272:1661-1665.
20. Edwards KM, Dupont WD, Westrich MK, Plummer WD Jr, Palmer PS, Wright PF. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis 1994; 169:68-76.
21. Treanor JJ, Mattison HR, Dumyati G et al. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Ann Intern Med 1992; 117:625-633.
22. Gorse GJ, O'Connor TZ, Young SL et al. Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study. Vaccine 2003; 21:2133-2144.
23. Gorse GJ, O'Connor TZ, Young SL et al. Impact of a winter respiratory virus season on patients with COPD and association with influenza vaccination. Chest 2006; 130:1109-1116.
24. Jackson L, Gaglani M, Keyserling H et al. Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons. BMC Infect Dis 2010; 10:71.
25. Levin MJ, Song LY, Fenton T et al. Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children. Vaccine 2008; 26:4210-4217.
26. Belshe RB, Ambrose C, Yi T. Safety and efficacy of live attenuated influenza vaccine in children 2-7years of age. Vaccine 2008; 26S:D10-D16.
27. Rhorer J, Ambrose CS, Dickinson S et al. Efficacy of live attenuated influenza vaccine in children: a meta-analysis of nine randomized clinical trials. Vaccine 2009; 27:1101-1110.
28. Jefferson T, Rivetti A, Harnden A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2008; CD004879.
29. Zangwill KM, Belshe RB. Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination. Pediatr Infect Dis J 2004; 23:189-197.
30. Negri E, Colombo C, Giordano L, Groth N, Apolone G, La Vecchia C. Influenza vaccine in healthy children: a meta-analysis. Vaccine 2005; 23:2851-2861.
31. Cox RJ, Brokstad KA, Ogra P. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol 2004; 59:1-15.
32. Johnson PR, Feldman S, Thompson JM, Mahoney JD, Wright PF. Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. J Infect Dis 1986; 154:121-127.